You are here

Article Text

Article menu
Download PDFPDF
Letter
The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer’s disease in men
  1. D J Lehmann1,
  2. E Hogervorst1,
  3. D R Warden1,
  4. A D Smith1,
  5. H T Butler2,
  6. J Ragoussis2
  1. 1Oxford Project to Investigate Memory and Ageing (OPTIMA), Radcliffe Infirmary, Oxford and University Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, UK
  2. 2Genomics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford
  1. Correspondence to:
 D J Lehmann;
 donald. lehmannpharm.ox.ac.uk

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We recently reported1 that the glutamine (CAG) repeat polymorphism of exon 1 of the androgen receptor was associated with Alzheimer’s disease in men from the Oxford region. If this androgen receptor polymorphism indeed affects Alzheimer’s disease risk rather than being in linkage disequilibrium with the true risk factor, then we should see the effect through androgen receptor actions. The association should, for instance, be influenced by ligands of the androgen receptor. Androgen receptor isoforms are the main, perhaps sole, receptors for the principal mammalian androgens, testosterone and 5α-dihydrotestosterone. On binding ligand, the receptor moves from the cytoplasm to specific compartments of the nucleus (“nuclear foci”), where it interacts with coactivators and corepressors in the cell specific regulation of numerous genes. We therefore looked for an interaction in Alzheimer’s disease risk of the androgen receptor CAG polymorphism with serum concentrations of total testosterone.

    We studied 207 elderly men, 79 with sporadic Alzheimer’s disease (mean (SD) onset age, 70 (9) years) and 128 controls (mean age, 75 (10) years), all from the cohort of the Oxford Project to Investigate Memory and Ageing (OPTIMA). Of the 79 Alzheimer cases, 45 were …

    View Full Text